The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries

Archive ouverte

Calvier, Laurent | Martinez-Martinez, Ernesto | Miana, Maria | Cachofeiro, Victoria | Rousseau, Elodie | Sádaba, J Rafael | Zannad, Faiez | Rossignol, Patrick | López-Andrés, Natalia

Edité par CCSD ; Elsevier/American College of Cardiology -

International audience. OBJECTIVES:This study investigated whether galectin (Gal)-3 inhibition could block aldosterone-induced cardiac and renal fibrosis and improve cardiorenal dysfunction.BACKGROUND:Aldosterone is involved in cardiac and renal fibrosis that is associated with the development of cardiorenal injury. However, the mechanisms of these interactions remain unclear. Gal-3, a β-galactoside-binding lectin, is increased in heart failure and kidney injury.METHODS:Rats were treated with aldosterone-salt combined with spironolactone (a mineralocorticoid receptor antagonist) or modified citrus pectin (a Gal-3 inhibitor), for 3 weeks. Wild-type and Gal-3 knockout mice were treated with aldosterone for 3 weeks. Hemodynamic, cardiac, and renal parameters were analyzed.RESULTS:Hypertensive aldosterone-salt-treated rats presented cardiac and renal hypertrophy (at morphometric, cellular, and molecular levels) and dysfunction. Cardiac and renal expressions of Gal-3 as well as levels of molecular markers attesting fibrosis were also augmented by aldosterone-salt treatment. Spironolactone or modified citrus pectin treatment reversed all of these effects. In wild-type mice, aldosterone did not alter blood pressure levels but increased cardiac and renal Gal-3 expression, fibrosis, and renal epithelial-mesenchymal transition. Gal-3 knockout mice were resistant to aldosterone effects.CONCLUSIONS:In experimental hyperaldosteronism, the increase in Gal-3 expression was associated with cardiac and renal fibrosis and dysfunction but was prevented by pharmacological inhibition (modified citrus pectin) or genetic disruption of Gal-3. These data suggest a key role for Gal-3 in cardiorenal remodeling and dysfunction induced by aldosterone. Gal-3 could be used as a new biotarget for specific pharmacological interventions.

Consulter en ligne

Suggestions

Du même auteur

Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation

Archive ouverte | Martinez-Martinez, Ernesto | CCSD

International audience. Interleukin-33 (IL-33) but not soluble ST2 (sST2) exerts anti-inflammatory and protective effects in several tissues. Aldosterone, a proinflammatory mediator which promotes adipogenesis, is e...

Galectin-3 mediates aldosterone-induced vascular fibrosis.

Archive ouverte | Calvier, Laurent | CCSD

International audience. OBJECTIVE: Aldosterone (Aldo) is involved in arterial stiffness and heart failure, but the mechanisms have remained unclear. Galectin-3 (Gal-3), a β-galactoside-binding lectin, plays an impor...

Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance

Archive ouverte | Martinez-Martinez, Ernesto | CCSD

International audience. Hypertensive cardiac remodeling is accompanied by molecular inflammation and fibrosis, 2 mechanisms that finally affect cardiac function. At cardiac level, aldosterone promotes inflammation a...

Chargement des enrichissements...